NCT02802735View on ClinicalTrials.gov

Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 22, 2016

Primary Completion Date

August 5, 2016

Study Completion Date

August 5, 2016

Conditions
Pharmacokinetics
Interventions
DRUG

Apremilast

Tablet for oral administration

DRUG

Placebo

Tablet for oral administration

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT02802735 - Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects | Biotech Hunter | Biotech Hunter